FDA Inspection 1012620 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on May 18, 2017 in Midwest City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 18, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Midwest City, OK (United States)